Market sentiment signals for Phathom Pharmaceuticals (PHAT): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
8 analysts
Options Flow (P/C)
0.00
More calls — Bullish
Avg Consensus PT
$18
+150.4%
Highest Price Target
$26
+272.0%
Lowest Price Target
$5
-28.5%
Short Interest
13.2%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Leerink Partners | Daniel Clark— | +43.1% | $10 | Initiate | Market Perform |
| Aug 17, 2026 | Barclays | Glen Santangelo— | +100.3% | $18 → $14 | Maintained | Overweight |
